Browse regulations

Detailed immigration regulations specifying exceptions to visa requirements, special immigrant classifications, and procedures for various categories including family-based, employment-based, and special immigrants such as religious workers, military personnel, and victims of terrorism

These regulations implement complex immigration laws that affect millions of people. Removing them would create chaos in the immigration system, separating families, disrupting employment-based immigration, and eliminating humanitarian protections for vulnerable groups. The costs of maintaining order and preventing humanitarian crises outweigh the regulatory burden.

This regulation implements passport and visa requirements for nonimmigrant aliens entering the United States, defining key terms (adjacent islands, cruise ship, ferry, pleasure vessel) and listing exemptions for specific categories (military personnel, Canadians with NEXUS/FAST, Bermudians, Bahamians, Mexican Border Crossing Card holders, etc.). It establishes the Visa Bond Pilot Program requiring bonds from certain nationalities, prescribes visa symbols, and sets classification criteria for foreign officials and grounds for refusal.

Americans would be worse off because this regulation provides essential structure for implementing immigration laws, balancing security with legitimate travel through exemptions and waivers. Deleting it would cause inconsistent enforcement, increased overstays, and loss of trusted traveler programs. Its nuanced approach—from NATO personnel exemptions to the Visa Bond Pilot—would be hard to replicate without creating bureaucratic chaos.

FDA classification system for orthopedic devices requiring premarket approval, special controls, and extensive compliance burdens based on risk categorization (Class I-III). Defines specific devices (arthroscopes, spinal implants, bone fixation devices, etc.) and mandates manufacturers obtain FDA clearance before commercial distribution.

Imposes massive compliance costs that stifle innovation, raise healthcare prices, and protect incumbent manufacturers from competition. The hidden tax exceeds $14,000 per household while delaying life-saving devices. Violates constitutional federalism by usurping state authority. Unseen costs—lost innovation, reduced supply, higher prices—far outweigh any marginal safety benefits beyond what tort liability and market mechanisms already provide.

FDA regulation (21 CFR Part 886) classifies ophthalmic medical devices into three risk categories (Class I, II, III) with escalating premarket requirements. Class I devices have general controls, Class II require special controls, and Class III need premarket approval. The regulation specifies exemption criteria, grandfathering provisions, and detailed requirements for specific devices ranging from simple tools like visual acuity charts to complex diagnostic software, controlling which devices can be marketed and under what conditions.

This federal premarket regulation violates constitutional federalism, imposing massive compliance costs ($ billions annually) that fall disproportionately on small businesses and stifle innovation. It creates regulatory capture, protecting incumbent manufacturers from competition while delaying life-improving devices from reaching patients. The unseen costs—higher healthcare prices, reduced competition, and foregone medical advances—far outweigh any marginal safety benefits that could be achieved through state regulation, tort law, and private certification. Bureaucratic knowledge problems and mission creep make centralized control inherently ineffective and incompatible with liberty and free enterprise principles.

This FDA regulation classifies dental devices into three risk-based categories (Class I, II, III) with varying premarket and postmarket requirements. It establishes specific classifications for hundreds of dental products, from simple instruments to complex imaging systems, and sets forth rules for exemptions, special controls, and premarket approval processes.

This regulation represents federal overreach into an area properly regulated by states and the market. It imposes substantial compliance costs on dental device manufacturers—particularly small businesses—creates barriers to innovation, and centralizes authority that would be better handled through competitive federalism. Dental device safety can be adequately addressed through state medical boards, tort liability, and private third-party certification without the $2 trillion annual regulatory burden this system adds to the economy.

This regulation classifies clinical chemistry and clinical toxicology devices (primarily in vitro diagnostic test systems) into FDA Classes I, II, or III, specifying premarket review requirements, exemptions, and special controls for hundreds of specific tests. It sets the framework for determining which devices require PMA or 510(k) clearance before commercial distribution.

The regulation imposes crushing compliance costs (part of the $2T annual burden), disproportionately harms small businesses, creates barriers to entry that protect incumbents, and represents federal overreach into health matters reserved to the states. Its unintended consequences include higher healthcare prices, stifled innovation, and reduced competition. Market mechanisms, tort liability, and state oversight can adequately ensure accuracy without this heavy-handed regime.

FDA monograph establishing conditions for OTC antiemetic drugs to be GRAS/GRAE. Specifies four permitted active ingredients, mandatory identity/indications/warnings/directions labeling with precise dosage ranges and age restrictions, and additional professional-use indications.

Regulation imposes massive compliance costs, stifles innovation in drug formulations, and restricts consumer choice. Prescriptive requirements create barriers to entry favoring large corporations, block tailored medical solutions, and represent federal overreach into personal health decisions better governed by market forces and state oversight. The unseen burden contributes to the $14,000 annual hidden tax per household.

FDA monograph establishing conditions for specific OTC topical drug products (first aid antibiotics, antifungals, acne treatments) to be generally recognized as safe and effective. Dictates permissible active ingredients, exact concentrations, authorized combinations, and mandatory labeling language. Compliance avoids classification as misbranded or unapproved new drugs.

Constitutional federalism violation: federalizes low-risk consumer products properly under state jurisdiction. Economic harms: entrenches incumbents via barriers to entry, stifles innovation through locked-in ingredient lists, imposes heavy compliance costs that disproportionately burden small businesses, and raises consumer prices. Replaces market mechanisms and liability with centralized bureaucratic control.

FDA regulation (21 CFR 312) requires investigational new drug applications (INDs) before human clinical trials, establishes safety monitoring, labeling restrictions ('Caution: New Drug—Limited to investigational use'), prohibits promotion/commercialization, sets rules for charging patients, and defines sponsor/investigator responsibilities. Exemptions apply to certain studies of already-marketed drugs, in vitro diagnostics, and placebo trials.

Repeal would eliminate enforceable safety standards for human subjects, leading to increased harm, exploitation of vulnerable patients, and unreliable scientific data that could allow unsafe drugs to reach market. The centralized FDA review prevents irreversible damage and systemic corruption of medical evidence that tort law and private certification cannot reliably prevent given asymmetric information and the need for ex ante oversight in high-risk, irreversible interventions. The regulation achieves its protective purpose in a way decentralized alternatives cannot, making repeal a net danger to public health despite compliance costs.

Establishes procedural rules for the Benefits Review Board's appellate jurisdiction over workers' compensation claims under multiple federal statutes, including filing deadlines, representation rules, and fee structures.

Creates a complex bureaucratic framework for appeals that increases costs and delays for injured workers while benefiting lawyers and administrators. The extensive procedural requirements and fee regulations distort the compensation process and reduce direct benefits to claimants.

Establishes the Benefits Review Board within the Department of Labor as a quasi-judicial body to hear appeals from decisions under federal workers' compensation statutes (Longshore and Harbor Workers' Compensation Act, Defense Base Act, etc.). Defines terms, composition, membership, quorum rules, and representation requirements.

Deleting this regulation would eliminate the procedural framework that ensures due process and predictability for workers appealing federal compensation decisions; the board's specialized expertise and established procedures lower transaction costs, and alternatives like ad hoc rules or federal courts would be less efficient and accessible.

This regulation mandates a federal Quality Control program for state unemployment compensation agencies. States must establish independent QC units, conduct statistical sampling of benefit payments and revenue collections, perform investigations, maintain records, and submit standardized reports to the Department of Labor. The Department provides oversight, technical assistance, and may allocate resources; the program includes detailed requirements for claimant notifications, determination notices, and employer separation information.

The program imposes substantial compliance costs on states, requiring dedicated units and extensive data collection that may be disproportionate to the benefits. It duplicates state accountability mechanisms, infringes on state sovereignty through conditional funding, and risks creating bureaucratic fixation on error-rate metrics rather than actual service quality. Federal oversight could be achieved more efficiently through periodic audits, leaving states to design their own quality controls suited to local needs.

Regulation implements 39 U.S.C. 3220, governing use of Postal Service penalty mail to publicize missing children. Requires posters from National Center for Missing and Exploited Children to be displayed in Board field offices and published in internal newsletter 'All-A-Board'. Posters must be removed after three months or when no longer useful.

Not a core constitutional function; uses federal resources for a cause better handled by private charities and state/local authorities; sets precedent for expanding federal role in social awareness campaigns; even low-cost programs accumulate and distort proper role of government. Unseen effect: normalization of federal activism beyond enumerated powers.

This regulation implements the Administrative False Claims Act for the Railroad Retirement Board, establishing procedures to impose civil penalties (up to $5,000 per claim/statement plus potential assessments of twice the paid amount) on persons who submit false or fraudulent claims or written statements to the agency. It defines key terms, sets liability standards (including 'reckless disregard' and 'deliberate ignorance' without requiring specific intent to defraud), outlines investigation and hearing procedures before the Civilian Board of Contract Appeals, and provides for collection and appeals.

This regulation creates a redundant, specialized enforcement regime for the Railroad Retirement Board—a mandatory federal pension program that exceeds constitutional federalism principles and could be handled by states or private entities. The penalty structure imposes severe liability ($5,000 per violation plus treble damages) without requiring fraudulent intent, creating significant abuse risks. It establishes an expensive bureaucratic apparatus to police fraud that is itself a symptom of distorted government benefit programs. The existing federal False Claims Act already provides adequate recourse for fraud against the government, rendering this parallel system an unnecessary expansion of regulatory power that burdens respondents with complex procedures and threatens chilling effects on legitimate claims.

This FERC regulation establishes procedures for calculating and collecting annual charges from natural gas pipelines, public utilities, and oil pipelines to reimburse the federal government for the costs of administering energy regulatory programs. It defines covered entities, sets payment deadlines with interest penalties, provides a waiver process for financial hardship, specifies accounting requirements, and allocates charges based on usage metrics (megawatt-hours for electricity, gas volumes for pipelines, revenues for oil).

This charge system perpetuates unconstitutional federal overreach into intrastate energy markets, violating Tenth Amendment principles. The compliance and reporting burden represents deadweight loss, with costs ultimately passed to consumers. By funding its own operations through regulated entities, FERC faces a structural incentive to expand regulatory reach to justify its budget—a classic case of regulatory capture where the foxes design the henhouse. The complex formulas and mandatory reporting requirements create barriers to entry, disproportionately harming small operators while protecting incumbents. The entire regime rests on an invalidated Chevron-era interpretation of agency authority, making its funding mechanism illegitimate.